WallStreetZenWallStreetZen

NASDAQ: WHWK
Whitehawk Therapeutics Inc Stock Ownership - Who owns Whitehawk Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Whitehawk Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Caley CasteleinDirector2026-05-14255,102$3.92
$1,000.00kBuy
David James LennonCHIEF EXECUTIVE OFFICER2026-05-1451,021$3.92
$200.00kBuy
Scott M. GiacobelloCHIEF FINANCIAL OFFICER2026-05-1438,265$3.92
$150.00kBuy
Margaret DuganChief Medical Officer2026-05-1419,132$3.92
$75.00kBuy
Bryan BallChief Technical Operations Officer2026-05-1451,020$3.92
$200.00kBuy
Scott M. GiacobelloCHIEF FINANCIAL OFFICER2026-04-16141,600$4.13
$584.81kSell
Scott M. GiacobelloCHIEF FINANCIAL OFFICER2026-04-1577,000$3.86
$297.22kSell
Bryan BallChief Technical Operations Officer and SVP Manufacturing Operations2026-04-1492,460$3.64
$336.55kSell
Bryan BallChief Technical Operations Officer and SVP Manufacturing Operations2026-04-1326,389$3.46
$91.31kSell
Bryan BallChief Technical Operations Officer and SVP Manufacturing Operations2026-04-106,596$3.43
$22.62kSell

1 of 2

WHWK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when WHWK insiders and whales buy or sell their stock.

WHWK Shareholders

What type of owners hold Whitehawk Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter11.37%5,621,835$23.39MInsider
Chau Quang Khuong10.50%5,193,946$21.61MInsider
Orbimed Advisors LLC10.50%5,193,946$21.61MInsider
Qvt Financial LP9.33%4,615,709$19.20MInstitution
Orbimed Advisors LLC8.42%4,166,000$17.33MInstitution
Novartis Bioventures Ltd8.19%4,049,804$16.85MInsider
Suvretta Capital Management LLC7.48%3,700,000$15.39MInstitution
Caley Castelein7.39%3,652,202$15.19MInsider
Behzad Aghazadeh7.02%3,471,752$14.44MInsider
Anupam Dalal6.90%3,411,532$14.19MInsider

1 of 3

WHWK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
WHWK45.73%54.27%Net SellingNet Selling
KROS67.09%32.91%Net SellingNet Buying
NERV53.55%46.45%
CAMP60.47%39.53%Net Buying
LENZ52.97%47.03%Net SellingNet Buying
View Top Biotech Stocks

Whitehawk Therapeutics Stock Ownership FAQ

Who owns Whitehawk Therapeutics?

Whitehawk Therapeutics (NASDAQ: WHWK) is owned by 69.26% institutional shareholders, 82.20% Whitehawk Therapeutics insiders, and 0.00% retail investors. Muneer A. Satter is the largest individual Whitehawk Therapeutics shareholder, owning 5.62M shares representing 11.37% of the company. Muneer A. Satter's Whitehawk Therapeutics shares are currently valued at $23.05M.

If you're new to stock investing, here's how to buy Whitehawk Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.